Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Share-based Compensation (2019 - 2026)

InMed Pharmaceuticals has reported Share-based Compensation over the past 5 years, most recently at $25564.0 for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 10.38% year-over-year to $25564.0; the TTM value through Dec 2025 reached $22609.0, down 84.55%, while the annual FY2025 figure was $28964.0, 78.97% down from the prior year.
  • Share-based Compensation for Q4 2025 was $25564.0 at InMed Pharmaceuticals, up from $20205.0 in the prior quarter.
  • Over five years, Share-based Compensation peaked at $214779.0 in Q4 2021 and troughed at -$63614.0 in Q2 2025.
  • A 5-year average of $66027.5 and a median of $40466.5 in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: grew 26.8% in 2024 and later crashed 263.31% in 2025.
  • Year by year, Share-based Compensation stood at $214779.0 in 2021, then tumbled by 67.11% to $70638.0 in 2022, then crashed by 74.14% to $18264.0 in 2023, then grew by 26.8% to $23159.0 in 2024, then grew by 10.38% to $25564.0 in 2025.
  • Business Quant data shows Share-based Compensation for INM at $25564.0 in Q4 2025, $20205.0 in Q3 2025, and -$63614.0 in Q2 2025.